BUY
Original-Research: ZEAL Network SE - from NuWays AG
Classification of NuWays AG to ZEAL Network SE
Company Name: ZEAL Network SE
ISIN: DE000ZEAL241
Reason for the research: Update
Recommendation: BUY
from: 06.03.2024
Target price: 51.00
Target price on sight of: 12 Monaten
Last rating change:
Analyst: Henry Wendisch
Q4 preview: tough comp for lottery, games still small
Topic: ZEAL should release final FY'23 figures on March 20th. Here's what we expect for Q4'23e:
Tough comp for lottery: Against a strong Q4'22 (peaking EuroJackpot), total German lottery spending (on & offline) has declined by 9% yoy in Q4'23 (+3% yoy for FY'23; Source: DLTB). For ZEAL it should also be hard to exceed its strong Q4'22, as we expect a slight yoy decline of 3% to € 208m in billings in Q4'23e. On a a FY'23e basis however, solid billings growth of 11% yoy to € 841m (guidance: € 800-830m) should be in the cards thanks to 1.15m MAU (eNuW; +7.5% yoy) and an ABPU of € 61.00 (eNuW; +3.2% yoy). With an average Lottery gross margin of 12.6% (eNuW), FY'23e sales from Lottery should grow accordingly by of 6% yoy to € 106m (Q4: € 26.8m, -9% yoy).
Next data point of Games roll-out: While the new segment 'Games' showed strong KPIs in its first quarter after introduction (Q3'23), we expect further improvements in Q4, as more games were added and lottery players should have been cross-sold. However, as regulatory approval takes more time than anticipated, we expect conservative sales of € 1.9m (vs. € 1.2m in Q3), based on an slightly increased pay-in for games of € 3.9m (vs. € 3.3m for Q3'23) and a constant pay-in to billings ratio.
Guidance well in reach: We expect ZEAL to exceed its lottery billings guidance of € 800-830m (eNuW: € 841m) while the sales (€ 110-120m; eNuW: € 115m) and EBITDA (€ 30-35m; eNuW: € 33.4m) guidance should be reached at mid-point.
Promising FY'24e outlook: While we expect Lottery sales to grow by 12% yoy to € 119m (driven by continuous marketing driven user intake), the Games business should also have first meaningful sales contribution of € 10m, implying total sales growth of 18% yoy. As ZEAL currently targets existing lottery players for its Games business, we model no marketing expenses for Games while € 42m should be spent on Lottery for brand awareness & customer acquisition. However, as user KPIs for Games look attractive (Q3'23 ARPU: € 7.67 at Lottery vs. € 22.02 at Games), additional € 3-8m of marketing expenses could be spent on Games in return for more user intake during FY'24e.
Against this backdrop, the recent share price weakness should be a buying opportunity, especially as Q1'24 saw extraordinary strong jackpots already, indicating a promising start into a strong growth year. Reiterate BUY with unchanged PT of € 51.00, based on DCF.
You can download the research here:
http://www.more-ir.de/d/29071.pdf
For additional information visit our website
www.nuways-ag.com/research.
Contact for questions
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.
Kontakt für Rückfragen
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++
-------------------transmitted by EQS Group AG.-------------------
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.